Ambit Iberia's Blog
Latest Developments in Digital Transformation in the Pharmaceutical, Biotechnology, and Medical Device Sectors
Pharma
How to save time and resources in the validation process through digitalization
The pharmaceutical industry needs increasingly efficient validation processes. It is here where digitalization is revealed as a powerful support when...
Keys to the Successful Commercialization of Medical Devices in the EU and USA
In a world where health innovation advances by leaps and bounds, the commercialization of medical devices presents unprecedented opportunities to...
Qualification vs. validation: The guide you need to distinguish them
Computer system validation and equipment qualification are fundamental requirements that determine the success of your pharmaceutical company. In...
Data integrity: Practical guide to compliance
Maintaining data integrity in the Life Sciences sector is essential to ensuring the reliability, accuracy and traceability of the information used in...
Stories that inspire, technology that transforms: Partner Insights 2025 has arrived
At Ambit Iberia, we firmly believe that true progress occurs when innovation is combined with collaboration. Under this premise, we launch the second...
La nueva ICH E6(R3): Por qué la validación en entornos GCP ya no es opcional
As of July 23, 2025, the new version of the ICH E6(R3) guideline comes into force, a key document marking a before and after in how clinical studies...
Practical summary of the new ISPE digital validation guide
Following the publication of the new ISPE Good Practice Guide: Digital Validation, a comprehensive guide on how to adopt, implement, and govern 100%...
How much risk are you taking with your non-validated systems?
The pharmaceutical and biotechnology industry in Spain is going through a crucial phase marked by digital transformation, regulatory evolution, and...
ISPE Europe Annual Conference 2026: Core Foundations of Data Integrity
Participating in the ISPE Europe Annual Conference 2026 was a great opportunity not only to share our experience implementing a Data Integrity...
Clean & Black Utilities in Pharma: Differences for Your GMP Control
In a pharmaceutical manufacturing plant, not everything that sustains production is visible at first glance. Behind every process, auxiliary systems...
AI in GxP Environments: The Questions We Can No Longer Put Off
Over the past few years, Artificial Intelligence has moved from being an emerging technology to becoming an increasingly tangible reality in the Life...
Ambit Iberia and The Triality Group announce Partnership to accelerate Trusted Artificial Intelligence in Life Sciences
Ambit Iberia, a leading Life Sciences consultancy specializing in Pharma & Biotech, Digital Solutions, and Medical Devices, is proud to announce a...
The new validation challenges: Saving time and resources in the Pharmaceutical and Biotechnology Industry
The concept of digitalization in the pharmaceutical and biotechnology industry emerged in the final decades of the 20th century, with systems that...
Digital Kit: What it is, how to apply for it, and how to make the most of it with us
Get the results you are looking for by taking advantage of the digital kit with us.
The Kit Digital is an initiative of the Government of Spain...
5 reasons why you should use GXPharma, validated private cloud service for the pharmaceutical industry and regulated environments
GxPharmaCloud is a private cloud solution located in one of the most secure datacenters in Spain and holds the TIER IV GOLD certification.
...